Labcorp (LH) Tops Q1 EPS by 13c, Offers Guidance

Labcorp (NYSE: LH) reported Q1 EPS of $6.11, $0.13 better than the analyst estimate of $5.98. Revenue for the quarter came in at $3.9 billion versus the consensus estimate of $4 billion.

GUIDANCE:

Labcorp sees FY2022 EPS of $18.25-$21.00, versus the consensus of $19.54.

For earnings history and earnings-related data on Labcorp (LH) click here.

You May Also Be Interested In

• Rapid7, Inc. (RPD) Tops Q2 EPS by 9c; offers guidance
• DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q2 EPS
• Viant Technology Inc. (DSP) Tops Q2 EPS by 9c